Calcification of poly(2-hydroxyethyl methacrylate)-collagen composites implanted in rats

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Biocompatibility Studies

Background:

• Poly(2-hydroxyethyl methacrylate) (polyHEMA) based composites are explored for biomedical uses.
• Collagen incorporation influences the properties and degradation of polyHEMA materials.
• Understanding the long-term behavior of these composites in vivo is crucial for application development.

Purpose of the Study:

• To evaluate the in vivo calcification and biodegradation of polyHEMA-collagen composites.
• To determine the effect of varying collagen content on the host response to implanted materials.
• To establish guidelines for the optimal use of polyHEMA-collagen composites based on their collagen percentage.

Main Methods:

• Implantation of polyHEMA-collagen composites with diverse collagen concentrations into the popliteal region of rats.
• Assessment of implant calcification using a radioactive indicator at 3, 6, and 12 months post-implantation.
• Histological examination of implants and surrounding tissues to evaluate degradation and host interaction.

Main Results:

• Implant calcification was directly correlated with collagen content, increasing with higher percentages.
• PolyHEMA-collagen composites containing 30% (w/w) or more collagen underwent significant biodegradation during long-term implantation.
• Lower collagen content (less than 20%) appeared more stable in vivo.

Conclusions:

• Collagen content critically affects the in vivo performance of polyHEMA-collagen composites, influencing both calcification and biodegradation.
• Composites with less than 20% fibrillar collagen are recommended for long-term biomedical applications.
• Composites with higher collagen content may be more suitable for in vitro investigations due to their accelerated degradation.